Gujarat Alkalies and Chemicals: General Updates. we would like to inform you that the Company has paid consideration of Rs. 26,000/- towards…
Gujarat Alkalies and Chemicals (GUJALKALI) filed a disclosure titled "General Updates. we would like to inform you that the Company has paid consideration of Rs. 26,000/- towards acquisition of 26% equity share capital (i.e. 2,600 equity shares of…". The…
What happened
Gujarat Alkalies and Chemicals (GUJALKALI) filed a disclosure with the exchanges on 13 November 2026 at 04:42 PM titled "General Updates. we would like to inform you that the Company has paid consideration of Rs. 26,000/- towards acquisition of 26% equity share capital (i.e. 2,600 equity shares of…".
Company snapshot
Gujarat Alkalies and Chemicals is a small-cap company in the Chemicals sector, with a market value of about ₹4,452 crore.
The stock last traded at ₹606.3, against a 52-week range of ₹409.2–₹815 (25.6% below the high).
Before this filing the shares had moved +1.0% over the month and −9.8% over three months. Average daily turnover over the last 20 sessions was about ₹23.23 crore.
Promoters held 47.28% at the end of Q2 FY27. Foreign institutions owned 3.26% and domestic institutions 2.70%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 1,083 | 16.3 | 2.23 |
| Q3 FY26 | 1,044 | -20 | -2.72 |
| Q4 FY26 | 1,125 | 15 | 2.04 |
| Q1 FY27 | 1,245 | 55 | 7.49 |
| Q2 FY27 | 1,358 | 82.6 | 11.24 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 5.8% on average the next trading day and was up 3.4% on average after five days (2 filings with price data).
Across 61 similar disclosures by other Chemicals companies, shares moved −1.1% on average the next day and −1.4% over five days; 31% of them rose the next day.
Market-wide, 2,455 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 50% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Jun 2026 | General Updates: The Company has paid total consideration of… | +5.9% | +3.4% |
| 11 Jun 2026 | Disclosure Of Information Under Regulation 30(2) Of The SEBI… | +5.9% | +3.4% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Gujarat Alkalies and Chemicals Limited to acquire 26% SPV stake
- Gujarat Alkalies uploads updated investor presentation for Sep 2026
- Earnings call transcript: Gujarat Alkalies posts strong Q2 FY 2027 gains By Investing.com
- Gujarat Alkalies targets ₹10,000 crore revenue by FY31; focuses on specialty chemicals, cost efficiency
- We Think That There Are Issues Underlying Gujarat Alkalies and Chemicals' (NSE:GUJALKALI) Earnings
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.